Research led by Michael Lan, PhD, Professor of Pediatrics and Genetics at LSU Health New Orleans School of Medicine, found that a compound named 5′-iodotubercidin (5′-IT) suppresses the growth of neuroblastoma cells and identified a potential new therapeutic approach for the disease.